BFRI · Biofrontera Inc. · Exempt Offerings
$0.92
-0.10 (-9.51%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management believes that these conditions raise substantial doubt about the Company's ability to continue as a going concern for at least twelve months from the issuance date of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 13, 2026
Market Cap
$16.19M
Shares
14.85M
Volume · Oct 5
621.81K
Avg daily vol (3M)
562.36K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-07-11 | New | Pharmaceuticals | $11,000,000 | $11,000,000 | 06b |
| 2024-12-05 | New | Pharmaceuticals | $4,200,000 | $4,200,000 | 06b |
| 2024-03-05 | New | Pharmaceuticals | $8,000,000 | $8,000,000 | 06b |
| 2022-11-04 | New | Pharmaceuticals | $3,683,209 | $3,683,209 | 06b |
| 2022-08-11 | New | Pharmaceuticals | $7,114,287 | $7,114,287 | 06b |
| 2022-05-23 | New | Pharmaceuticals | $9,400,681 | $9,400,681 | 06b |
| 2021-12-10 | New | Pharmaceuticals | $15,000,000 | $15,000,000 | 06b |
Showing 1–7 of 7 filings